Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Youngsters: Software of Allometric Scaling
There have been 13 monoclonal antibodies, seven polyclonal antibodies, and 9 therapeutic proteins (non-antibodies) within the examine. The clearance of therapeutic proteins was predicted utilizing the age dependent exponents (ADE) mannequin after which in contrast with the noticed clearance values.
There have been in whole 29 therapeutic proteins on this examine with 75 observations. The variety of observations with ≤30%, ≤50%, and >50% prediction error was 60 (80%), 72 (96%), and be 3 (4%), respectively. Total, the anticipated clearance values of therapeutic proteins in kids was good.
The allometric methodology proposed on this manuscript can be utilized to pick out first-in-pediatric dose of therapeutic proteins in pediatric medical trials.
A preliminary analysis of a regionally produced biotinylated polyclonal anti-rabies antibody for direct fast immunohistochemical take a look at (DRIT) within the Philippines
Subsequently, a biotinylated polyclonal antibody (pAb) towards the rabies lyssavirus (RABV) nucleoprotein was developed utilizing a plasmid cDNA vaccine derived from a problem virus commonplace 11 pressure. A preliminary analysis on the efficacy of this reagent in recognizing the Philippine RABV pressure was examined utilizing banked canine hippocampal tissue samples with DRIT and the outcomes had been in comparison with dFAT.
The consequences of acetone and formalin fixation on DRIT had been additionally assessed by way of immunoreactivity scores of the specimens. Of the 142 samples examined, 104 examined optimistic and 38 destructive utilizing each dFAT and DRIT, displaying 100% settlement between the 2 diagnostic procedures. Furthermore, no false optimistic or false destructive outcomes had been noticed utilizing acetone and formalin fixation.
Thus, regionally ready biotinylated pAb from plasmid cDNA can be utilized for DRIT, particularly in resource-limited laboratories within the Philippines. Nonetheless, these outcomes ought to be confirmed with a extra thorough analysis of this system, and the vary of detection must be additional evaluated in a bigger panel of animal samples and on different lyssav viruses.

PIBF1 Antibody |
|||
1-CSB-PA828391 | Cusabio |
|
|
Description: A polyclonal antibody against PIBF1. Recognizes PIBF1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
PIBF1 Antibody |
|||
1-CSB-PA889657 | Cusabio |
|
|
Description: A polyclonal antibody against PIBF1. Recognizes PIBF1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
PIBF1 Antibody |
|||
1-CSB-PA017961GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against PIBF1. Recognizes PIBF1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
Polyclonal PIBF1 Antibody |
|||
APR06805G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIBF1 . This antibody is tested and proven to work in the following applications: |
PIBF1 Conjugated Antibody |
|||
C38564 | SAB | 100ul | EUR 476.4 |
PIBF1 Conjugated Antibody |
|||
C31261 | SAB | 100ul | EUR 476.4 |
Polyclonal PIBF1 / PIBF Antibody (C-Terminus) |
|||
APR03127G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIBF1 / PIBF (C-Terminus). This antibody is tested and proven to work in the following applications: |
Progesterone-Induced-Blocking Factor 1 (PIBF1) Antibody |
|||
abx236433-100ug | Abbexa | 100 ug | EUR 577.2 |
Progesterone-Induced-Blocking Factor 1 (PIBF1) Antibody |
|||
20-abx126358 | Abbexa |
|
|
Progesterone-Induced-Blocking Factor 1 (PIBF1) Antibody |
|||
20-abx002214 | Abbexa |
|
|
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody |
|||
20-abx174168 | Abbexa |
|
|
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody |
|||
20-abx211035 | Abbexa |
|
|
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody |
|||
20-abx114691 | Abbexa |
|
|
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody |
|||
20-abx129293 | Abbexa |
|
|
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody |
|||
20-abx339511 | Abbexa |
|
|
PIBF1 siRNA |
|||
20-abx928540 | Abbexa |
|
|
PIBF1 Peptide |
|||
7237P | ProSci | 0.05 mg | EUR 197.7 |
Description: (CT) PIBF1 Peptide |
PIBF1 Rabbit pAb |
|||
A12033-100ul | Abclonal | 100 ul | EUR 369.6 |
PIBF1 Rabbit pAb |
|||
A12033-200ul | Abclonal | 200 ul | EUR 550.8 |
PIBF1 Rabbit pAb |
|||
A12033-20ul | Abclonal | 20 ul | EUR 219.6 |
PIBF1 Rabbit pAb |
|||
A12033-50ul | Abclonal | 50 ul | EUR 267.6 |
PIBF1 Rabbit pAb |
|||
A3072-100ul | Abclonal | 100 ul | EUR 369.6 |
PIBF1 Rabbit pAb |
|||
A3072-200ul | Abclonal | 200 ul | EUR 550.8 |
PIBF1 Rabbit pAb |
|||
A3072-20ul | Abclonal | 20 ul | EUR 219.6 |
PIBF1 Rabbit pAb |
|||
A3072-50ul | Abclonal | 50 ul | EUR 267.6 |
PIBF1 Blocking Peptide |
|||
33R-7990 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PIBF1 antibody, catalog no. 70R-9148 |
PIBF1 Blocking Peptide |
|||
DF7171-BP | Affbiotech | 1mg | EUR 234 |
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human) |
|||
4-PAN433Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1) |
Human PIBF1 ELISA Kit |
|||
ELA-E1563h | Lifescience Market | 96 Tests | EUR 988.8 |
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), PE |
|||
4-PAN433Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with PE. |
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), APC |
|||
4-PAN433Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with APC. |
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), Cy3 |
|||
4-PAN433Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with Cy3. |
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), FITC |
|||
4-PAN433Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with FITC. |
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), HRP |
|||
4-PAN433Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with HRP. |
Human PIBF1 shRNA Plasmid |
|||
20-abx957102 | Abbexa |
|
|
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAN433Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with Biotin. |
PIBF1 Recombinant Protein (Mouse) |
|||
RP161978 | ABM | 100 ug | Ask for price |
PIBF1 Recombinant Protein (Mouse) |
|||
RP161981 | ABM | 100 ug | Ask for price |
PIBF1 Recombinant Protein (Human) |
|||
RP083220 | ABM | 100 ug | Ask for price |
Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAN433Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with APC-Cy7. |
PIBF1 ORF Vector (Human) (pORF) |
|||
ORF027741 | ABM | 1.0 ug DNA | EUR 486 |
Pibf1 ORF Vector (Mouse) (pORF) |
|||
ORF053994 | ABM | 1.0 ug DNA | EUR 607.2 |
Pibf1 ORF Vector (Mouse) (pORF) |
|||
ORF053995 | ABM | 1.0 ug DNA | EUR 607.2 |
PIBF1 ELISA Kit (Human) (OKEH01125) |
|||
OKEH01125 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.34 ng/mL |
PIBF1 ELISA Kit (Human) (OKCD09391) |
|||
OKCD09391 | Aviva Systems Biology | 96 Wells | EUR 1090.8 |
Description: Description of target: PIBF1 is the mediator of progesterone that by acting on the phospholipase A2 enzyme interferes with arachidonic acid metabolism, induces a Th2 biased immune response, and by controlling NK activity exerts an anti-abortive effect.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.116ng/mL |
PIBF1 ELISA Kit (Mouse) (OKEI00591) |
|||
OKEI00591 | Aviva Systems Biology | 96 Wells | EUR 920.4 |
Description: Description of target: ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.469 ng/mL |
Pibf1 3'UTR GFP Stable Cell Line |
|||
TU166340 | ABM | 1.0 ml | Ask for price |
PIBF1 3'UTR GFP Stable Cell Line |
|||
TU067921 | ABM | 1.0 ml | EUR 1672.8 |
Pibf1 3'UTR GFP Stable Cell Line |
|||
TU266218 | ABM | 1.0 ml | Ask for price |
Pibf1 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4607801 | ABM | 3 x 1.0 ug | EUR 406.8 |
PIBF1 sgRNA CRISPR Lentivector set (Human) |
|||
K1646101 | ABM | 3 x 1.0 ug | EUR 406.8 |
PIBF1 Protein Vector (Human) (pPM-C-HA) |
|||
PV110964 | ABM | 500 ng | EUR 973.2 |
PIBF1 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV215976 | ABM | 500 ng | EUR 1278 |
PIBF1 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV215980 | ABM | 500 ng | EUR 723.6 |
PIBF1 Protein Vector (Human) (pPB-C-His) |
|||
PV110962 | ABM | 500 ng | EUR 394.8 |
PIBF1 Protein Vector (Human) (pPB-N-His) |
|||
PV110963 | ABM | 500 ng | EUR 973.2 |
PIBF1 Protein Vector (Human) (pPM-C-His) |
|||
PV110965 | ABM | 500 ng | EUR 973.2 |
PIBF1 Protein Vector (Mouse) (pPB-C-His) |
|||
PV215974 | ABM | 500 ng | EUR 1278 |
PIBF1 Protein Vector (Mouse) (pPB-N-His) |
|||
PV215975 | ABM | 500 ng | EUR 1278 |
PIBF1 Protein Vector (Mouse) (pPM-C-His) |
|||
PV215977 | ABM | 500 ng | EUR 1278 |
PIBF1 Protein Vector (Mouse) (pPB-C-His) |
|||
PV215978 | ABM | 500 ng | EUR 723.6 |
PIBF1 Protein Vector (Mouse) (pPB-N-His) |
|||
PV215979 | ABM | 500 ng | EUR 723.6 |
PIBF1 Protein Vector (Mouse) (pPM-C-His) |
|||
PV215981 | ABM | 500 ng | EUR 723.6 |
Pibf1 3'UTR Luciferase Stable Cell Line |
|||
TU116340 | ABM | 1.0 ml | Ask for price |
PIBF1 3'UTR Luciferase Stable Cell Line |
|||
TU017921 | ABM | 1.0 ml | EUR 1672.8 |
Pibf1 3'UTR Luciferase Stable Cell Line |
|||
TU216218 | ABM | 1.0 ml | Ask for price |
Pibf1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4607802 | ABM | 1.0 ug DNA | EUR 184.8 |
Pibf1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4607803 | ABM | 1.0 ug DNA | EUR 184.8 |
Pibf1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4607804 | ABM | 1.0 ug DNA | EUR 184.8 |
PIBF1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K1646102 | ABM | 1.0 ug DNA | EUR 184.8 |
PIBF1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K1646103 | ABM | 1.0 ug DNA | EUR 184.8 |
PIBF1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K1646104 | ABM | 1.0 ug DNA | EUR 184.8 |
Human Progesterone-induced-blocking factor 1 (PIBF1) |
|||
1-CSB-CF845171HU | Cusabio |
|
|
Description: Recombinant Human Progesterone-induced-blocking factor 1(PIBF1) expressed in in vitro E.coli expression system |
Recombinant Progesterone Immunomodulatory Binding Factor 1 (PIBF1) |
|||
4-RPN433Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Progesterone Immunomodulatory Binding Factor 1 expressed in: E.coli |
Acetylcholinesterase (AChE) polyclonal antibody from hybrid catfish (C. macrocephalus × C. gariepinus): Specification, sensitivity and cross reactivity
After that, the fish mind was dissected, AChE was extracted and purified by hydroxyapatite column chromatography and eluted with 0.2 M potassium phosphate buffer pH 6.8. This protocol gave 70% yield. Then, the mind extract was characterised utilizing 10% SDS-PAGE and Western blot probed with industrial polyclonal antibody particular to AChE (PAb-AChE). The protein, 71 kDa, was then used as an antigen to immunize mice for antibody manufacturing.
The polyclonal antibody (PAb) was characterised utilizing dot blot, Western blot and immunohistochemistry for immunolocalization of AChE in hybrid catfish uncovered to glyphosate. We discovered that the suitable dilution of antibody for each dot blot and Western blot was 1:3500, and 1:2500 for immunohistochemistry.
Cross reactivity testing confirmed that PAb-AChE can be utilized with AChE from striped snakehead fish on the similar dilution as used with AChE from hybrid catfish. It was concluded that PAb particular to hybrid catfish AChE from this work was extremely particular and delicate, and may cross-react with striped snakehead fish AChE. Thus, this polyclonal antibody could also be utilized in monitoring glyphosate publicity in hybrid catfish and striped snakehead fish.
ApoB antibody |
|||
20C-CR2009GP | Fitzgerald | 1 mg | EUR 198 |
Description: Goat polyclonal ApoB antibody (IgG Fraction) |
ApoB antibody |
|||
20C-CR2009RP | Fitzgerald | 1 mg | EUR 198 |
Description: Rabbit polyclonal ApoB antibody |
ApoB antibody |
|||
20C-CR2009SP | Fitzgerald | 1 ml | EUR 440.4 |
Description: Sheep polyclonal ApoB antibody (Purified IgG) |
ApoB antibody |
|||
20R-1695 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Goat polyclonal ApoB antibody |
ApoB antibody |
|||
20-AG40S | Fitzgerald | 5 ml | EUR 178.8 |
Description: Goat polyclonal ApoB antibody |
ApoB antibody |
|||
20-S1151G000-V0 | Fitzgerald | 10 ml | EUR 159.6 |
Description: Goat polyclonal Human ApoB antibody |
ApoB Antibody |
|||
BF0278 | Affbiotech | 200ul | EUR 540 |
ApoB antibody |
|||
70C-CR2009GAP | Fitzgerald | 1 mg | EUR 442.8 |
Description: Affinity purified Goat polyclonal ApoB antibody |
APOB antibody |
|||
70R-15771 | Fitzgerald | 50 ul | EUR 405.6 |
Description: Rabbit polyclonal APOB antibody |
ApoB antibody |
|||
70R-7483 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Rabbit polyclonal ApoB antibody raised against the middle region of APOB |
APOB Antibody |
|||
36751-100ul | SAB | 100ul | EUR 302.4 |
APOB Antibody |
|||
DF12533 | Affbiotech | 200ul | EUR 420 |
APOB Antibody |
|||
1-CSB-PA318254 | Cusabio |
|
|
Description: A polyclonal antibody against APOB. Recognizes APOB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:15-1:50 |
APOB Antibody |
|||
1-CSB-PA780260 | Cusabio |
|
|
Description: A polyclonal antibody against APOB. Recognizes APOB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:15-1:50 |
APOB Antibody |
|||
1-CSB-PA001918GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against APOB. Recognizes APOB from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
APOB Antibody |
|||
1-CSB-PA001918LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
APOB Antibody |
|||
R36144-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
Description: Additional name(s) for this target protein: Apolipoprotein B |
APOB Antibody |
|||
R32510 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Apolipoprotein B (ApoB) is a protein that in humans is encoded by the APOB gene. This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. |
Anti-Apolipoprotein B/APOB Antibody |
|||
PB10042 | BosterBio | 100ug/vial | EUR 400.8 |
APOB Antibody, HRP conjugated |
|||
1-CSB-PA001918LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
Apolipoprotein B (APOB) Antibody |
|||
abx230491-100ug | Abbexa | 100 ug | EUR 610.8 |
Apolipoprotein B (APOB) Antibody |
|||
20-abx175426 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx175427 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx171274 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx214431 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx214432 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx111022 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx101439 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx101440 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx101441 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx101443 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
abx432338-200ul | Abbexa | 200 ul | EUR 460.8 |
Apolipoprotein B (APOB) Antibody |
|||
20-abx000052 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody |
|||
20-abx001189 | Abbexa |
|
|
Apolipoprotein B (ApoB) Antibody |
|||
abx012218-100ul | Abbexa | 100 ul | EUR 493.2 |
Apolipoprotein B (APOB) Antibody |
|||
20-abx303086 | Abbexa |
|
|
APOB Antibody / Apolipoprotein B |
|||
V8941-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8941-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8941SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V9160-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V9160-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V9160SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8461-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8461-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8461SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8609-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8609-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene. |
APOB Antibody / Apolipoprotein B |
|||
V8609SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene. |
APOB Antibody, FITC conjugated |
|||
1-CSB-PA001918LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
APOB Antibody, Biotin conjugated |
|||
1-CSB-PA001918LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
APOB Conjugated Antibody |
|||
C36751 | SAB | 100ul | EUR 476.4 |
APOB Polyclonal Antibody |
|||
A71904 | EpiGentek |
|
|
APOB Polyclonal Antibody |
|||
A58102 | EpiGentek |
|
|
Mouse Anti-Human APOB Monoclonal Antibody |
|||
CABT-26570MH | Creative Diagnostics | 100ug | EUR 920.4 |
Apolipoprotein B (APOB) Antibody (HRP) |
|||
20-abx303087 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (FITC) |
|||
20-abx271183 | Abbexa |
|
|
Apolipoprotein B-100 (APOB) Antibody |
|||
20-abx132335 | Abbexa |
|
|
Apolipoprotein B-100 (APOB) Antibody |
|||
20-abx132342 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody Pair |
|||
20-abx370667 | Abbexa |
|
|
Apolipoprotein B-100 (APOB) Antibody |
|||
20-abx101442 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (FITC) |
|||
20-abx273657 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (FITC) |
|||
20-abx274081 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (FITC) |
|||
20-abx273903 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (FITC) |
|||
20-abx303088 | Abbexa |
|
|
Monoclonal ApoB Antibody, Clone: 6G6 |
|||
APG03156G | Leading Biology | 0.1ml | EUR 633.6 |
Description: A Monoclonal antibody against Human ApoB. The antibodies are raised in Mouse and are from clone 6G6. This antibody is applicable in WB, FC, ICC, E |
Apolipoprotein B (APOB) Antibody (Biotin) |
|||
20-abx271449 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (Biotin) |
|||
20-abx271777 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (Biotin) |
|||
20-abx272588 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (Biotin) |
|||
20-abx273087 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (Biotin) |
|||
20-abx274504 | Abbexa |
|
|
Apolipoprotein B (APOB) Antibody (Biotin) |
|||
20-abx303089 | Abbexa |
|
|
Apolipoprotein B Antibody / APOB |
|||
RQ5037 | NSJ Bioreagents | 100ul | EUR 356.15 |
Description: The APOB gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 (~240 kDa) and apoB-100 (~516 kDa): the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. [RefSeq] |
APOB Polyclonal Antibody, HRP Conjugated |
|||
A58105 | EpiGentek |
|
|
APOB Polyclonal Antibody, FITC Conjugated |
|||
A58104 | EpiGentek |
|
|
APOB Polyclonal Antibody, Biotin Conjugated |
|||
A58103 | EpiGentek |
|
|
Anti-APOB antibody |
|||
PAab00491 | Lifescience Market | 100 ug | EUR 463.2 |
Leave a Reply